Hot Features
プレミアム
Ionis Pharmaceuticals Inc (IONS)
NASDAQ
登録してリアルタイムのアラート、カスタムポートフォリオ、市場の動きを入手してください。
| 日付 | 保有者名 | 取引株数 | 金額レンジ ($) | 取引種別 | 価格レンジ ($) | 届出終了時の株数 | % 変化 |
|---|---|---|---|---|---|---|---|
| 2026-06-01 | Dr. Spencer Robert BerthelsenIndependent Director | -8.00k | 410.00k | Derivative Exercise and Sale | 24.42 - 75.67 | 156.08k | - |
| 2026-05-13 | Dr. Brett P. MoniaFounder, CEO & Director | -4.54k | 208.14k | Derivative Exercise and Sale | 32.60 - 78.68 | 242.66k | - |
| 2026-05-04 | Dr. Joseph LoscalzoIndependent Chairman of the Board | -77.29k | 2.03M | Derivative Exercise and Sale | 38.06 - 75.58 | 36.33k | - |
| 2026-05-01 | Mr. Joseph KleinIndependent Director | -10.11k | 266.91k | Derivative Exercise and Sale | 47.11 - 74.45 | 11.11k | - |
| 2026-04-28 | Mr. Joseph T. BaroldiExec. VP & Chief Business Officer | -1.63k | 116.73k | Automatic Disposition | 71.79 | 49.26k | -3.20% |
| 2026-04-15 | Ms. B. Lynne ParshallDirector | -5.00k | 381.37k | Automatic Disposition | 76.19 - 76.97 | 51.34k | -8.87% |
| 2026-04-15 | Mr. Kyle JenneExec. VP & Chief Global Product Strategy Officer | -4.90k | 368.49k | Derivative Exercise and Sale | 75.17 | 23.71k | - |
| 2026-04-15 | Mr. Kyle JenneExec. VP & Chief Global Product Strategy Officer | 7.32k | 0.00 | Derivative Exercise and Retained Stock | - | 23.71k | 44.69% |
| 2026-04-15 | Mr. Joseph T. BaroldiExec. VP & Chief Business Officer | -5.62k | 418.95k | Derivative Exercise and Sale | 74.56 | 50.88k | - |
| 2026-04-15 | Mr. Joseph T. BaroldiExec. VP & Chief Business Officer | 5.22k | 0.00 | Derivative Exercise and Retained Stock | - | 50.88k | 11.43% |
| 2026-04-15 | Mr. Brian BirchlerExec. VP of Corporate & Development Operations | -973.00 | 73.02k | Derivative Exercise and Sale | 75.04 | 67.50k | - |
| 2026-04-15 | Mr. Brian BirchlerExec. VP of Corporate & Development Operations | 902.00 | 0.00 | Derivative Exercise and Retained Stock | - | 67.50k | 1.35% |
| 2026-04-01 | Mr. Joseph KleinIndependent Director | -22.32k | 805.60k | Derivative Exercise and Sale | 38.06 - 75.95 | 11.11k | - |
| 2026-04-02 | Ms. Shannon L. Devers DeversExec. VP & Chief Human Resource Officer | -6.19k | 458.61k | Automatic Disposition | 74.05 | 16.35k | -27.47% |
| 2026-03-19 | Dr. Eugene SchneiderExec. VP, Chief Clinical Development & Operations Officer | -5.81k | 412.49k | Automatic Disposition | 70.97 | 63.89k | -8.34% |
| 2026-03-16 | Ms. Elizabeth L. HougenExec. VP of Finance & CFO | -175.00k | 3.68M | Derivative Exercise and Sale | 32.60 - 72.38 | 82.66k | - |
| 2026-03-16 | Ms. Elizabeth L. HougenExec. VP of Finance & CFO | -50.22k | 3.65M | Automatic Disposition | 72.38 - 73.21 | 82.66k | -37.79% |
| 2026-03-10 | Mr. Kyle JenneExec. VP & Chief Global Product Strategy Officer | -37.28k | 1.16M | Derivative Exercise and Sale | 34.69 - 76.30 | 16.39k | - |
| 2026-03-09 | Dr. Brett P. MoniaFounder, CEO & Director | -148.45k | 2.15M | Derivative Exercise and Sale | 60.89 - 76.34 | 242.66k | - |
| 2026-03-09 | Dr. Brett P. MoniaFounder, CEO & Director | -12.32k | 927.65k | Automatic Disposition | 75.26 - 75.58 | 242.66k | -4.83% |
| 2026-03-09 | Mr. Patrick R. O'NeilExec. VP, Chief Legal Officer, General Counsel & Corporate Secretary | -10.15k | 763.66k | Automatic Disposition | 75.25 | 62.21k | -14.02% |
| 2026-03-03 | Dr. Joseph LoscalzoIndependent Chairman of the Board | -1.03k | 43.55k | Derivative Exercise and Sale | 38.06 - 80.33 | 36.33k | - |
| 2026-03-03 | Mr. Joseph T. BaroldiExec. VP & Chief Business Officer | -2.14k | 76.45k | Derivative Exercise and Sale | 32.60 - 80.41 | 45.66k | - |
| 2026-03-03 | Mr. Joseph T. BaroldiExec. VP & Chief Business Officer | -4.52k | 359.25k | Automatic Disposition | 79.36 - 81.01 | 45.66k | -9.01% |
| 2026-03-03 | Dr. C. Frank BennettExec. VP & Chief Scientific Officer | -65.09k | 1.65M | Derivative Exercise and Sale | 32.60 - 79.10 | 80.55k | - |
| 2026-03-03 | Dr. C. Frank BennettExec. VP & Chief Scientific Officer | -20.00k | 1.59M | Automatic Disposition | 79.10 - 80.76 | 80.55k | -19.89% |
| 2026-03-03 | Ms. Shannon L. Devers DeversExec. VP & Chief Human Resource Officer | -20.11k | 873.18k | Derivative Exercise and Sale | 32.60 - 80.84 | 22.54k | - |
| 2026-03-03 | Ms. Allene Maria DiazIndependent Director | -40.32k | 1.59M | Derivative Exercise and Sale | 38.06 - 79.88 | 3.81k | - |
| 2026-03-03 | Ms. Allene Maria DiazIndependent Director | -14.56k | 1.16M | Automatic Disposition | 79.88 - 80.80 | 3.81k | -79.25% |
| 2026-03-03 | Mr. Joseph KleinIndependent Director | -16.00k | 616.70k | Derivative Exercise and Sale | 40.05 - 80.00 | 11.11k | - |
| 2026-03-03 | Mr. Joseph KleinIndependent Director | -5.33k | 427.37k | Automatic Disposition | 80.00 - 80.82 | 11.11k | -32.42% |
| 2026-02-02 | Dr. C. Frank BennettExec. VP & Chief Scientific Officer | 0.00 | 0.00 | Other Disposition | - | 100.29k | 0.00% |
| 2026-02-11 | Ms. B. Lynne ParshallDirector | -5.00k | 413.59k | Automatic Disposition | 82.72 | 56.34k | -8.15% |
| 2026-02-13 | Dr. Eric E. SwayzeExec. VP of Research | -15.64k | 1.28M | Automatic Disposition | 81.56 - 82.07 | 32.42k | -32.54% |
| 2026-02-06 | Dr. Brett P. MoniaFounder, CEO & Director | -29.43k | 2.52M | Automatic Disposition | 85.79 | 254.50k | -10.37% |
| 2026-02-02 | Dr. C. Frank BennettExec. VP & Chief Scientific Officer | -65.09k | 1.91M | Derivative Exercise and Sale | 32.60 - 83.03 | 100.29k | - |
| 2026-02-02 | Dr. C. Frank BennettExec. VP & Chief Scientific Officer | -20.00k | 1.65M | 売り | 82.60 | 100.29k | -16.63% |
| 2026-01-30 | Mr. Brian BirchlerExec. VP of Corporate & Development Operations | -6.18k | 513.05k | 売り | 83.03 | 66.25k | -8.53% |
| 2026-01-30 | Ms. Elizabeth L. HougenExec. VP of Finance & CFO | -6.99k | 581.70k | 売り | 83.24 | 132.88k | -5.00% |
| 2026-01-30 | Dr. Brett P. MoniaFounder, CEO & Director | -62.97k | 5.21M | 売り | 82.72 | 283.93k | -18.15% |
| 2026-01-30 | Dr. Eugene SchneiderExec. VP, Chief Clinical Development & Operations Officer | -6.18k | 515.63k | 売り | 83.45 | 69.70k | -8.14% |
| 2026-01-30 | Mr. Patrick R. O'NeilExec. VP, Chief Legal Officer, General Counsel & Corporate Secretary | -6.18k | 516.15k | 売り | 83.53 | 71.98k | -7.91% |
| 2026-01-30 | Dr. Eric E. SwayzeExec. VP of Research | -6.18k | 512.45k | 売り | 82.93 | 48.07k | -11.39% |
| 2026-01-30 | Mr. Joseph T. BaroldiExec. VP & Chief Business Officer | -5.30k | 439.36k | 売り | 82.96 | 50.19k | -9.55% |
| 2026-01-30 | Dr. C. Frank BennettExec. VP & Chief Scientific Officer | -5.89k | 488.14k | 売り | 82.95 | 100.29k | -5.54% |
| 2026-01-22 | Ms. Shannon L. Devers DeversExec. VP & Chief Human Resource Officer | -3.98k | 323.49k | Automatic Disposition | 81.34 | 22.54k | -15.00% |
| 2026-01-15 | Dr. Eric E. SwayzeExec. VP of Research | 11.54k | 0.00 | Derivative Exercise and Retained Stock | - | 42.25k | 37.59% |
| 2026-01-15 | Dr. Eric E. SwayzeExec. VP of Research | -9.93k | 748.38k | Derivative Exercise and Sale | 75.34 - 75.97 | 42.25k | - |
| 2026-01-15 | Dr. Eugene SchneiderExec. VP, Chief Clinical Development & Operations Officer | 12.38k | 0.00 | Derivative Exercise and Retained Stock | - | 63.89k | 24.04% |
| 2026-01-15 | Dr. Eugene SchneiderExec. VP, Chief Clinical Development & Operations Officer | -9.30k | 703.14k | Derivative Exercise and Sale | 75.59 | 63.89k | - |
| 2026-01-15 | Mr. Michael J. YangIndependent Director | 1.93k | 0.00 | Derivative Exercise and Retained Stock | - | 7.94k | 32.11% |
| 2026-01-15 | Dr. Brett P. MoniaFounder, CEO & Director | 45.11k | 0.00 | Derivative Exercise and Retained Stock | - | 224.68k | 25.12% |
| 2026-01-15 | Dr. Brett P. MoniaFounder, CEO & Director | -44.03k | 3.29M | Derivative Exercise and Sale | 74.82 | 224.68k | - |
| 2026-01-15 | Mr. Patrick R. O'NeilExec. VP, Chief Legal Officer, General Counsel & Corporate Secretary | 12.28k | 0.00 | Derivative Exercise and Retained Stock | - | 66.17k | 22.79% |
| 2026-01-15 | Mr. Patrick R. O'NeilExec. VP, Chief Legal Officer, General Counsel & Corporate Secretary | -9.19k | 697.05k | Derivative Exercise and Sale | 75.84 | 66.17k | - |
| 2026-01-15 | Ms. Elizabeth L. HougenExec. VP of Finance & CFO | 15.81k | 0.00 | Derivative Exercise and Retained Stock | - | 126.31k | 14.30% |
| 2026-01-15 | Ms. Elizabeth L. HougenExec. VP of Finance & CFO | -12.92k | 971.99k | Derivative Exercise and Sale | 75.22 | 126.31k | - |
| 2026-01-15 | Dr. Holly KordasiewiczExec. VP & Chief Development Officer | 6.98k | 0.00 | Derivative Exercise and Retained Stock | - | 14.72k | 90.16% |
| 2026-01-15 | Dr. Holly KordasiewiczExec. VP & Chief Development Officer | -4.14k | 313.31k | Derivative Exercise and Sale | 75.66 | 14.72k | - |
| 2026-01-15 | Mr. Kyle JenneExec. VP & Chief Global Product Strategy Officer | 5.19k | 0.00 | Derivative Exercise and Retained Stock | - | 16.39k | 46.34% |
| 2026-01-15 | Mr. Kyle JenneExec. VP & Chief Global Product Strategy Officer | -1.82k | 138.48k | Derivative Exercise and Sale | 75.96 | 16.39k | - |
| 2026-01-15 | Mr. Joseph T. BaroldiExec. VP & Chief Business Officer | 11.83k | 0.00 | Derivative Exercise and Retained Stock | - | 45.20k | 35.45% |
| 2026-01-15 | Mr. Joseph T. BaroldiExec. VP & Chief Business Officer | -8.06k | 610.28k | Derivative Exercise and Sale | 75.75 - 75.78 | 45.20k | - |
| 2026-01-15 | Mr. Brian BirchlerExec. VP of Corporate & Development Operations | 11.61k | 0.00 | Derivative Exercise and Retained Stock | - | 60.44k | 23.78% |
| 2026-01-15 | Mr. Brian BirchlerExec. VP of Corporate & Development Operations | -8.48k | 636.93k | Derivative Exercise and Sale | 75.11 | 60.44k | - |
| 2026-01-15 | Dr. C. Frank BennettExec. VP & Chief Scientific Officer | 12.08k | 0.00 | Derivative Exercise and Retained Stock | - | 94.76k | 14.61% |
| 2026-01-15 | Dr. C. Frank BennettExec. VP & Chief Scientific Officer | -8.98k | 674.62k | Derivative Exercise and Sale | 75.15 | 94.76k | - |
| 2026-01-15 | Ms. Shannon L. Devers DeversExec. VP & Chief Human Resource Officer | 9.02k | 0.00 | Derivative Exercise and Retained Stock | - | 26.52k | 51.58% |
| 2026-01-15 | Ms. Shannon L. Devers DeversExec. VP & Chief Human Resource Officer | -8.35k | 634.41k | Derivative Exercise and Sale | 75.95 | 26.52k | - |
| 2026-01-07 | Ms. Shannon L. Devers DeversExec. VP & Chief Human Resource Officer | -44.20k | 1.50M | Derivative Exercise and Sale | 32.60 - 85.36 | 17.49k | - |
| 2026-01-02 | Dr. Eric E. SwayzeExec. VP of Research | -23.46k | 427.66k | Derivative Exercise and Sale | 60.89 - 79.27 | 30.71k | - |
| 2025-12-01 | Mr. Joseph Harris WenderLead Independent Director | -28.00k | 2.26M | Automatic Disposition | 80.67 - 81.23 | 52.04k | -34.98% |
| 2025-11-25 | Mr. Joseph KleinIndependent Director | -12.00k | 960.00k | Derivative Exercise and Sale | 80.00 | 16.45k | - |
| 2025-11-25 | Ms. Shannon L. Devers DeversExec. VP & Chief Human Resource Officer | -16.78k | 455.34k | Derivative Exercise and Sale | 53.77 - 80.91 | 17.49k | - |
| 2025-11-19 | Ms. Joan Elizabeth HermanIndependent Director | -44.00k | 648.43k | Derivative Exercise and Sale | 40.05 - 72.13 | 46.09k | - |
| 2025-11-18 | Mr. Joseph Harris WenderLead Independent Director | 16.00k | 390.72k | Derivative Exercise and Retained Stock | 24.42 | 80.04k | 24.99% |
| 2025-10-31 | Dr. Richard S. GearyStrategic Consultant | -70.93k | 1.15M | Derivative Exercise and Sale | 56.78 - 75.11 | 59.66k | - |
| 2025-11-05 | Dr. Richard S. GearyStrategic Consultant | -34.64k | 576.51k | Derivative Exercise and Sale | 56.78 - 76.10 | 59.66k | - |
| 2025-11-06 | Mr. Brian BirchlerExec. VP of Corporate & Development Operations | -8.00k | 609.38k | Automatic Disposition | 76.17 | 48.83k | -14.08% |
| 2025-10-31 | Dr. Joseph LoscalzoIndependent Chairman of the Board | -16.00k | 366.15k | Derivative Exercise and Sale | 52.22 - 75.10 | 36.33k | - |
| 2025-10-31 | Dr. Richard S. GearyStrategic Consultant | -20.00k | 1.50M | Automatic Disposition | 75.11 | 59.66k | -25.11% |
| 2025-10-30 | Mr. Joseph Harris WenderLead Independent Director | -28.00k | 2.07M | Automatic Disposition | 72.19 - 75.16 | 64.04k | -30.42% |
| 2025-10-06 | Dr. Brett P. MoniaFounder, CEO & Director | -437.00 | 30.27k | Automatic Disposition | 69.26 | 179.57k | -0.24% |
| 2025-10-06 | Mr. Joseph T. BaroldiExec. VP & Chief Business Officer | -1.63k | 112.73k | Automatic Disposition | 69.37 | 33.37k | -4.64% |
| 2025-10-06 | Mr. Patrick R. O'NeilExec. VP, Chief Legal Officer, General Counsel & Corporate Secretary | -10.20k | 173.58k | Derivative Exercise and Sale | 52.87 - 69.89 | 53.89k | - |
| 2025-10-06 | Mr. Patrick R. O'NeilExec. VP, Chief Legal Officer, General Counsel & Corporate Secretary | -3.24k | 224.49k | Automatic Disposition | 69.27 | 53.89k | -5.67% |
| 2025-10-06 | Dr. Eric E. SwayzeExec. VP of Research | -6.85k | 472.72k | Automatic Disposition | 69.02 | 30.64k | -18.27% |
| 2025-10-02 | Mr. Joseph T. BaroldiExec. VP & Chief Business Officer | -15.00k | 543.21k | Derivative Exercise and Sale | 31.80 - 68.01 | 35.00k | - |
| 2025-10-02 | Mr. Patrick R. O'NeilExec. VP, Chief Legal Officer, General Counsel & Corporate Secretary | -64.66k | 563.80k | Derivative Exercise and Sale | 56.78 - 67.69 | 57.13k | - |
| 2025-10-01 | Mr. Joseph Harris WenderLead Independent Director | -16.80k | 1.10M | Automatic Disposition | 65.50 | 92.04k | -15.44% |
| 2025-10-01 | Dr. Eric E. SwayzeExec. VP of Research | -27.11k | 335.82k | Derivative Exercise and Sale | 53.77 - 66.23 | 37.49k | - |
| 2025-09-29 | Mr. Patrick R. O'NeilExec. VP, Chief Legal Officer, General Counsel & Corporate Secretary | -25.30k | 198.39k | Derivative Exercise and Sale | 56.78 - 64.68 | 57.13k | - |
| 2025-09-30 | Ms. Elizabeth L. HougenExec. VP of Finance & CFO | -49.80k | 571.99k | Derivative Exercise and Sale | 53.77 - 65.26 | 110.50k | - |
| 2025-09-30 | Dr. Richard S. GearyStrategic Consultant | -57.90k | 664.39k | Derivative Exercise and Sale | 53.77 - 65.24 | 79.66k | - |
| 2025-09-12 | Mr. Patrick R. O'NeilExec. VP, Chief Legal Officer, General Counsel & Corporate Secretary | -1.70k | 13.26k | Derivative Exercise and Sale | 56.78 - 64.58 | 57.13k | - |
| 2025-09-09 | Mr. Patrick R. O'NeilExec. VP, Chief Legal Officer, General Counsel & Corporate Secretary | -21.00k | 81.08k | Derivative Exercise and Sale | 56.78 - 64.56 | 57.13k | - |
| 2025-09-09 | Mr. Joseph T. BaroldiExec. VP & Chief Business Officer | -11.95k | 362.83k | Derivative Exercise and Sale | 31.80 - 62.16 | 35.00k | - |
| 2025-09-05 | Mr. Joseph T. BaroldiExec. VP & Chief Business Officer | -250.00 | 7.55k | Derivative Exercise and Sale | 31.80 - 62.00 | 35.00k | - |
| 2025-09-05 | Dr. C. Frank BennettExec. VP & Chief Scientific Officer | -6.00k | 357.58k | Automatic Disposition | 59.60 | 82.68k | -6.77% |
| 2025-09-02 | Dr. Eric E. SwayzeExec. VP of Research | -11.13k | 552.86k | Automatic Disposition | 49.22 - 53.68 | 37.49k | -22.89% |
| 2025-09-02 | Mr. Joseph Harris WenderLead Independent Director | -28.00k | 1.61M | Automatic Disposition | 55.04 - 60.14 | 108.84k | -20.46% |
| 2025-09-02 | Ms. B. Lynne ParshallDirector | -20.00k | 1.02M | Automatic Disposition | 50.42 - 51.49 | 66.34k | -23.16% |
| 2025-09-03 | Dr. Brett P. MoniaFounder, CEO & Director | -203.81k | 3.26M | Derivative Exercise and Sale | 32.60 - 61.06 | 180.01k | - |
| 2025-09-03 | Ms. Shannon L. Devers DeversExec. VP & Chief Human Resource Officer | -3.16k | 78.74k | Derivative Exercise and Sale | 32.60 - 61.02 | 15.94k | - |
| 2025-09-02 | Dr. Richard S. GearyStrategic Consultant | -10.00k | 503.67k | Automatic Disposition | 50.37 | 79.66k | -11.15% |
| 2025-09-03 | Mr. Joseph KleinIndependent Director | -28.00k | 1.68M | Derivative Exercise and Sale | 60.00 | 16.45k | - |
| 2025-09-03 | Mr. Joseph T. BaroldiExec. VP & Chief Business Officer | -32.80k | 903.18k | Derivative Exercise and Sale | 31.80 - 62.01 | 35.00k | - |
| 2025-09-03 | Dr. Joseph LoscalzoIndependent Chairman of the Board | -16.00k | 571.65k | Derivative Exercise and Sale | 24.42 - 60.15 | 36.33k | - |
| 2025-09-02 | Mr. Patrick R. O'NeilExec. VP, Chief Legal Officer, General Counsel & Corporate Secretary | -89.90k | 1.34M | Derivative Exercise and Sale | 32.60 - 61.42 | 57.13k | - |
| 2025-09-03 | Dr. C. Frank BennettExec. VP & Chief Scientific Officer | -46.80k | 331.92k | Derivative Exercise and Sale | 53.77 - 61.50 | 88.68k | - |
| 2025-09-02 | Dr. C. Frank BennettExec. VP & Chief Scientific Officer | -5.00k | 245.70k | Automatic Disposition | 49.14 | 88.68k | -5.34% |
| 2025-09-03 | Dr. Eugene SchneiderExec. VP, Chief Clinical Development & Operations Officer | -19.66k | 138.41k | Derivative Exercise and Sale | 53.77 - 61.42 | 51.51k | - |
| 2025-08-22 | Ms. Allene Maria DiazIndependent Director | -1.43k | 60.69k | Automatic Disposition | 42.53 | 18.37k | -7.21% |
| 2025-08-18 | Dr. C. Frank BennettExec. VP & Chief Scientific Officer | -10.00k | 113.78k | Derivative Exercise and Sale | 32.60 - 43.98 | 93.47k | - |
| 2025-08-06 | Ms. B. Lynne ParshallDirector | -5.00k | 209.65k | Automatic Disposition | 41.87 - 42.63 | 86.34k | -5.47% |
| 2025-08-05 | Dr. Richard S. GearyStrategic Consultant | -10.00k | 428.59k | Automatic Disposition | 42.86 | 89.49k | -10.05% |
| 2025-08-04 | Dr. Eugene SchneiderExec. VP, Chief Clinical Development & Operations Officer | -9.55k | 408.70k | Automatic Disposition | 42.80 | 51.51k | -15.64% |
| 2025-07-30 | Dr. Brett P. MoniaFounder, CEO & Director | -2.43k | 30.16k | Derivative Exercise and Sale | 32.60 - 45.00 | 179.82k | - |
| 2025-07-15 | Dr. Joseph LoscalzoIndependent Chairman of the Board | 4.08k | 0.00 | Derivative Exercise and Retained Stock | - | 36.33k | 12.65% |
| 2025-07-15 | Mr. Joseph Harris WenderLead Independent Director | 4.08k | 0.00 | Derivative Exercise and Retained Stock | - | 136.84k | 3.07% |
| 2025-07-15 | Mr. Michael J. YangIndependent Director | 4.08k | 0.00 | Derivative Exercise and Retained Stock | - | 6.01k | 211.24% |
| 2025-07-15 | Dr. Spencer Robert BerthelsenIndependent Director | 4.08k | 0.00 | Derivative Exercise and Retained Stock | - | 156.08k | 2.68% |
| 2025-07-15 | Dr. Michael R. HaydenIndependent Director | 4.08k | 0.00 | Derivative Exercise and Retained Stock | - | 56.30k | 7.81% |
| 2025-07-15 | Ms. Allene Maria DiazIndependent Director | 4.08k | 0.00 | Derivative Exercise and Retained Stock | - | 19.80k | 25.95% |
| 2025-07-15 | Ms. Joan Elizabeth HermanIndependent Director | 4.08k | 0.00 | Derivative Exercise and Retained Stock | - | 46.09k | 9.71% |
| 2025-07-15 | Ms. B. Lynne ParshallDirector | 4.08k | 0.00 | Derivative Exercise and Retained Stock | - | 91.34k | 4.67% |
| 2025-07-11 | Dr. Brett P. MoniaFounder, CEO & Director | -1.16k | 48.42k | Automatic Disposition | 41.74 | 179.82k | -0.64% |
ご覧いただいた銘柄が下記のボックス内に表示されますので、過去閲覧した銘柄情報に簡単にアクセスすることができます。
顧客サポート: +44 (0) 203 8794 460 | support@advfn.com
ADVFNのサービスをご利用いただくには、利用規約
メールアドレスで登録
すでにアカウントをお持ちですか？ サインイン
アカウントをお持ちでないですか？ 登録
登録することで、ADVFN の 利用規約 を読み、理解し、同意したこと、および私が個人投資家であることを確認します。
